Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing unoprostone isopropyl (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Unoprostone isopropyl (substance) |
Inferred relationship |
Some |
1 |
Topical form unoprostone isopropyl |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Unoprostone isopropyl (substance) |
Inferred relationship |
Some |
|
Unoprostone isopropyl 1.5 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Unoprostone isopropyl (substance) |
Inferred relationship |
Some |
|
Product containing unoprostone isopropyl in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Unoprostone isopropyl (substance) |
Inferred relationship |
Some |
|
Unoprostone isopropyl-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Unoprostone isopropyl (substance) |
Inferred relationship |
Some |
1 |
Unoprostone isopropyl only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Unoprostone isopropyl (substance) |
Inferred relationship |
Some |
1 |
Product containing only unoprostone isopropyl in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Unoprostone isopropyl (substance) |
Inferred relationship |
Some |
1 |
Unoprostone isopropyl 1.5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Unoprostone isopropyl (substance) |
Inferred relationship |
Some |
1 |
Unoprostone isopropyl 1.5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Unoprostone isopropyl (substance) |
Inferred relationship |
Some |
1 |